Stomach cancer survivor back on her feet after heated chemotherapy clinical trial

Faye Hood was training for a half-marathon in 2017, when the active then-70-year-old received a stomach cancer diagnosis. While she put her half-marathon goals on hold for stomach cancer treatment, she knew it was exercise that helped her stay otherwise healthy and made her a strong candidate for an aggressive clinical trial involving heated chemotherapy — also called hyperthermic intraperitoneal perfusion with chemotherapy (HIPEC). “I know my doctor wouldn’t have recommended me for the study if I wasn’t strong enough for it,” she says. Coming to MD Anderson for stomach cancer treatment Faye had been shocked to learn that she had stage IV stomach cancer. She thought the symptoms she’d experienced – bloating and other bowel troubles – were just part of aging. She quickly decided to seek treatment at MD Anderson. She had learned of the hospital’s reputation through family and friends, and it was only about four hours from her home in Pineville, Louisiana. Faye doesn’t remember the details of her first visit to MD Anderson in September 2017, but she does remember the way MD Anderson made her feel. “We walked in the door, and there was just such a welcoming atmosphere,” she says. While at MD Anderson, Faye met with oncologist Mariela Blum Murphy, M.D. They discussed her health history and scheduled an endoscopy to ensure she had an accurate diagnosis. Following the endoscopy, she made plans to undergo nine cycles of chemotherapy and have a surgical consultation. Choosing a HIPEC clinical trial to treat stomach cancer Faye met with Brian Badgwell, M.D., a stomach cancer surgeon, to discuss the next phase of her treatment....